Infectious Disease Diagnostics Market Size, Share Report, Analysis, Trends, Growth 2028

Infectious Disease Diagnostics Market

Infectious Disease Diagnostics Market By Product (Reagents, Kits, and Consumables, Instruments, and Software & Services), By Type of Testing (Laboratory Testing, and POC Testing), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays, and Other Technologies), By Disease Type (COVID-19, HIV, HAIs, Hepatitis, CT/NG, HPV, TB, Influenza, and Other Infectious Diseases), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, and Other End Users), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 - 2028

Category: Medical Device Report Format : PDF Pages: 190 Report Code: ZMR-2145 Published Date: May-2022 Status : Published
Market Size in 2021 Market Forecast in 2028 CAGR (in %) Base Year
USD 28.15 Billion USD 42 Billion 6.9% 2021

Infectious Disease Diagnostics Market

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Infectious Disease Diagnostics Market, (2022 - 2028) (USD Million)
    • 2.2 Global Infectious Disease Diagnostics Market : snapshot
  • Chapter 3. Global Infectious Disease Diagnostics Market - Industry Analysis
    • 3.1 Infectious Disease Diagnostics Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 The global prevalence of infectious diseases and onset of COVID-19
    • 3.3 Market Restraints
      • 3.3.1. Lack of accuracy of point of care diagnostic tests and Unfavorable reimbursement scenario
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Product
      • 3.7.2 Market attractiveness analysis By Type of Testing
      • 3.7.3 Market attractiveness analysis By Technology
      • 3.7.4 Market attractiveness analysis By Disease Type
      • 3.7.5 Market attractiveness analysis By End-User
  • Chapter 4. Global Infectious Disease Diagnostics Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Infectious Disease Diagnostics Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Infectious Disease Diagnostics Market - Product Analysis
    • 5.1 Global Infectious Disease Diagnostics Market overview: By Product
      • 5.1.1 Global Infectious Disease Diagnostics Market share, By Product, 2021 and 2028
    • 5.2 Reagents, Kits, and Consumables
      • 5.2.1 Global Infectious Disease Diagnostics Market by Reagents, Kits, and Consumables, 2022 - 2028 (USD Million)
    • 5.3 Instruments
      • 5.3.1 Global Infectious Disease Diagnostics Market by Instruments, 2022 - 2028 (USD Million)
    • 5.4 Software & Services
      • 5.4.1 Global Infectious Disease Diagnostics Market by Software & Services, 2022 - 2028 (USD Million)
  • Chapter 6. Global Infectious Disease Diagnostics Market - Type of Testing Analysis
    • 6.1 Global Infectious Disease Diagnostics Market overview: By Type of Testing
      • 6.1.1 Global Infectious Disease Diagnostics Market share, By Type of Testing, 2021 and 2028
    • 6.2 Laboratory Testing
      • 6.2.1 Global Infectious Disease Diagnostics Market by Laboratory Testing, 2022 - 2028 (USD Million)
    • 6.3 POC Testing
      • 6.3.1 Global Infectious Disease Diagnostics Market by POC Testing, 2022 - 2028 (USD Million)
  • Chapter 7. Global Infectious Disease Diagnostics Market - Technology Analysis
    • 7.1 Global Infectious Disease Diagnostics Market overview: By Technology
      • 7.1.1 Global Infectious Disease Diagnostics Market share, By Technology, 2021 and 2028
    • 7.2 Immunodiagnostics
      • 7.2.1 Global Infectious Disease Diagnostics Market by Immunodiagnostics, 2022 - 2028 (USD Million)
    • 7.3 Clinical Microbiology
      • 7.3.1 Global Infectious Disease Diagnostics Market by Clinical Microbiology, 2022 - 2028 (USD Million)
    • 7.4 PCR
      • 7.4.1 Global Infectious Disease Diagnostics Market by PCR, 2022 - 2028 (USD Million)
    • 7.5 INAAT
      • 7.5.1 Global Infectious Disease Diagnostics Market by INAAT, 2022 - 2028 (USD Million)
    • 7.6 DNA Sequencing & NGS
      • 7.6.1 Global Infectious Disease Diagnostics Market by DNA Sequencing & NGS, 2022 - 2028 (USD Million)
    • 7.7 DNA Microarrays
      • 7.7.1 Global Infectious Disease Diagnostics Market by DNA Microarrays, 2022 - 2028 (USD Million)
    • 7.8 Other technologies
      • 7.8.1 Global Infectious Disease Diagnostics Market by Other technologies, 2022 - 2028 (USD Million)
  • Chapter 8. Global Infectious Disease Diagnostics Market - Disease Type Analysis
    • 8.1 Global Infectious Disease Diagnostics Market overview: By Disease Type
      • 8.1.1 Global Infectious Disease Diagnostics Market share, By Disease Type, 2021 and 2028
    • 8.2 COVID-19
      • 8.2.1 Global Infectious Disease Diagnostics Market by COVID-19, 2022 - 2028 (USD Million)
    • 8.3 HIV
      • 8.3.1 Global Infectious Disease Diagnostics Market by HIV, 2022 - 2028 (USD Million)
    • 8.4 HAIs
      • 8.4.1 Global Infectious Disease Diagnostics Market by HAIs, 2022 - 2028 (USD Million)
    • 8.5 Hepatitis
      • 8.5.1 Global Infectious Disease Diagnostics Market by Hepatitis, 2022 - 2028 (USD Million)
    • 8.6 CT/NG
      • 8.6.1 Global Infectious Disease Diagnostics Market by CT/NG, 2022 - 2028 (USD Million)
    • 8.7 HPV
      • 8.7.1 Global Infectious Disease Diagnostics Market by HPV, 2022 - 2028 (USD Million)
    • 8.8 TB
      • 8.8.1 Global Infectious Disease Diagnostics Market by TB, 2022 - 2028 (USD Million)
    • 8.9 Influenza
      • 8.9.1 Global Infectious Disease Diagnostics Market by Influenza, 2022 - 2028 (USD Million)
    • 8.10 Other Infectious Diseases
      • 8.10.1 Global Infectious Disease Diagnostics Market by Other Infectious Diseases, 2022 - 2028 (USD Million)
  • Chapter 9. Global Infectious Disease Diagnostics Market - End-User Analysis
    • 9.1 Global Infectious Disease Diagnostics Market overview: By End-User
      • 9.1.1 Global Infectious Disease Diagnostics Market share, By End-User, 2021 and 2028
    • 9.2 Diagnostic Laboratories
      • 9.2.1 Global Infectious Disease Diagnostics Market by Diagnostic Laboratories, 2022 - 2028 (USD Million)
    • 9.3 Hospitals & Clinics
      • 9.3.1 Global Infectious Disease Diagnostics Market by Hospitals & Clinics, 2022 - 2028 (USD Million)
    • 9.4 Academic Research Institutes
      • 9.4.1 Global Infectious Disease Diagnostics Market by Academic Research Institutes, 2022 - 2028 (USD Million)
    • 9.5 Other End Users
      • 9.5.1 Global Infectious Disease Diagnostics Market by Other End Users, 2022 - 2028 (USD Million)
  • Chapter 10. Infectious Disease Diagnostics Market - Regional Analysis
    • 10.1 Global Infectious Disease Diagnostics Market Regional Overview
    • 10.2 Global Infectious Disease Diagnostics Market Share, by Region, 2021 & 2028 (USD Million)
    • 10.3. North America
      • 10.3.1 North America Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
        • 10.3.1.1 North America Infectious Disease Diagnostics Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 North America Infectious Disease Diagnostics Market, by Product, 2022 - 2028
      • 10.4.1 North America Infectious Disease Diagnostics Market, by Product, 2022 - 2028 (USD Million)
    • 10.5 North America Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028
      • 10.5.1 North America Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028 (USD Million)
    • 10.6 North America Infectious Disease Diagnostics Market, by Technology, 2022 - 2028
      • 10.6.1 North America Infectious Disease Diagnostics Market, by Technology, 2022 - 2028 (USD Million)
    • 10.7 North America Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028
      • 10.7.1 North America Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028 (USD Million)
    • 10.8 North America Infectious Disease Diagnostics Market, by End-User, 2022 - 2028
      • 10.8.1 North America Infectious Disease Diagnostics Market, by End-User, 2022 - 2028 (USD Million)
    • 10.4. Europe
      • 10.4.2 Europe Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
        • 10.4.2.1 Europe Infectious Disease Diagnostics Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 Europe Infectious Disease Diagnostics Market, by Product, 2022 - 2028
      • 10.4.1 Europe Infectious Disease Diagnostics Market, by Product, 2022 - 2028 (USD Million)
    • 10.5 Europe Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028
      • 10.5.1 Europe Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028 (USD Million)
    • 10.6 Europe Infectious Disease Diagnostics Market, by Technology, 2022 - 2028
      • 10.6.1 Europe Infectious Disease Diagnostics Market, by Technology, 2022 - 2028 (USD Million)
    • 10.7 Europe Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028
      • 10.7.1 Europe Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028 (USD Million)
    • 10.8 Europe Infectious Disease Diagnostics Market, by End-User, 2022 - 2028
      • 10.8.1 Europe Infectious Disease Diagnostics Market, by End-User, 2022 - 2028 (USD Million)
    • 10.5. Asia Pacific
      • 10.5.3 Asia Pacific Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
        • 10.5.3.1 Asia Pacific Infectious Disease Diagnostics Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 Asia Pacific Infectious Disease Diagnostics Market, by Product, 2022 - 2028
      • 10.4.1 Asia Pacific Infectious Disease Diagnostics Market, by Product, 2022 - 2028 (USD Million)
    • 10.5 Asia Pacific Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028
      • 10.5.1 Asia Pacific Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028 (USD Million)
    • 10.6 Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2022 - 2028
      • 10.6.1 Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2022 - 2028 (USD Million)
    • 10.7 Asia Pacific Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028
      • 10.7.1 Asia Pacific Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028 (USD Million)
    • 10.8 Asia Pacific Infectious Disease Diagnostics Market, by End-User, 2022 - 2028
      • 10.8.1 Asia Pacific Infectious Disease Diagnostics Market, by End-User, 2022 - 2028 (USD Million)
    • 10.6. Latin America
      • 10.6.4 Latin America Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
        • 10.6.4.1 Latin America Infectious Disease Diagnostics Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 Latin America Infectious Disease Diagnostics Market, by Product, 2022 - 2028
      • 10.4.1 Latin America Infectious Disease Diagnostics Market, by Product, 2022 - 2028 (USD Million)
    • 10.5 Latin America Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028
      • 10.5.1 Latin America Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028 (USD Million)
    • 10.6 Latin America Infectious Disease Diagnostics Market, by Technology, 2022 - 2028
      • 10.6.1 Latin America Infectious Disease Diagnostics Market, by Technology, 2022 - 2028 (USD Million)
    • 10.7 Latin America Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028
      • 10.7.1 Latin America Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028 (USD Million)
    • 10.8 Latin America Infectious Disease Diagnostics Market, by End-User, 2022 - 2028
      • 10.8.1 Latin America Infectious Disease Diagnostics Market, by End-User, 2022 - 2028 (USD Million)
    • 10.7. The Middle-East and Africa
      • 10.7.5 The Middle-East and Africa Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
        • 10.7.5.1 The Middle-East and Africa Infectious Disease Diagnostics Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 The Middle-East and Africa Infectious Disease Diagnostics Market, by Product, 2022 - 2028
      • 10.4.1 The Middle-East and Africa Infectious Disease Diagnostics Market, by Product, 2022 - 2028 (USD Million)
    • 10.5 The Middle-East and Africa Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028
      • 10.5.1 The Middle-East and Africa Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028 (USD Million)
    • 10.6 The Middle-East and Africa Infectious Disease Diagnostics Market, by Technology, 2022 - 2028
      • 10.6.1 The Middle-East and Africa Infectious Disease Diagnostics Market, by Technology, 2022 - 2028 (USD Million)
    • 10.7 The Middle-East and Africa Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028
      • 10.7.1 The Middle-East and Africa Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028 (USD Million)
    • 10.8 The Middle-East and Africa Infectious Disease Diagnostics Market, by End-User, 2022 - 2028
      • 10.8.1 The Middle-East and Africa Infectious Disease Diagnostics Market, by End-User, 2022 - 2028 (USD Million)
  • Chapter 11. Company Profiles
    • 11.1 Abbott Laboratories (US)
      • 11.1.1 Overview
      • 11.1.2 Financials
      • 11.1.3 Product Portfolio
      • 11.1.4 Business Strategy
      • 11.1.5 Recent Developments
    • 11.2 F. Hoffmann-La Roche Ltd(Switzerland)
      • 11.2.1 Overview
      • 11.2.2 Financials
      • 11.2.3 Product Portfolio
      • 11.2.4 Business Strategy
      • 11.2.5 Recent Developments
    • 11.3 bioMérieux SA (France)
      • 11.3.1 Overview
      • 11.3.2 Financials
      • 11.3.3 Product Portfolio
      • 11.3.4 Business Strategy
      • 11.3.5 Recent Developments
    • 11.4 Thermo Fisher Scientific Inc. (US)
      • 11.4.1 Overview
      • 11.4.2 Financials
      • 11.4.3 Product Portfolio
      • 11.4.4 Business Strategy
      • 11.4.5 Recent Developments
    • 11.5 Danaher Corporation (US)
      • 11.5.1 Overview
      • 11.5.2 Financials
      • 11.5.3 Product Portfolio
      • 11.5.4 Business Strategy
      • 11.5.5 Recent Developments
    • 11.6 Quidel Corporation(US)
      • 11.6.1 Overview
      • 11.6.2 Financials
      • 11.6.3 Product Portfolio
      • 11.6.4 Business Strategy
      • 11.6.5 Recent Developments
    • 11.7 Hologic Inc. (US)
      • 11.7.1 Overview
      • 11.7.2 Financials
      • 11.7.3 Product Portfolio
      • 11.7.4 Business Strategy
      • 11.7.5 Recent Developments
    • 11.8 Siemens Healthineers AG (Germany)
      • 11.8.1 Overview
      • 11.8.2 Financials
      • 11.8.3 Product Portfolio
      • 11.8.4 Business Strategy
      • 11.8.5 Recent Developments
    • 11.9 Becton
      • 11.9.1 Overview
      • 11.9.2 Financials
      • 11.9.3 Product Portfolio
      • 11.9.4 Business Strategy
      • 11.9.5 Recent Developments
    • 11.10 Dickinson and Company (US)
      • 11.10.1 Overview
      • 11.10.2 Financials
      • 11.10.3 Product Portfolio
      • 11.10.4 Business Strategy
      • 11.10.5 Recent Developments
    • 11.11 PerkinElmer Inc. (US)
      • 11.11.1 Overview
      • 11.11.2 Financials
      • 11.11.3 Product Portfolio
      • 11.11.4 Business Strategy
      • 11.11.5 Recent Developments
    • 11.12 QIAGEN (Netherlands)
      • 11.12.1 Overview
      • 11.12.2 Financials
      • 11.12.3 Product Portfolio
      • 11.12.4 Business Strategy
      • 11.12.5 Recent Developments
    • 11.13 Grifols S.A. (Spain)
      • 11.13.1 Overview
      • 11.13.2 Financials
      • 11.13.3 Product Portfolio
      • 11.13.4 Business Strategy
      • 11.13.5 Recent Developments
    • 11.14 DiaSorin S.p.A (Italy)
      • 11.14.1 Overview
      • 11.14.2 Financials
      • 11.14.3 Product Portfolio
      • 11.14.4 Business Strategy
      • 11.14.5 Recent Developments
    • 11.15 Bio-Rad Laboratories Inc. (US)
      • 11.15.1 Overview
      • 11.15.2 Financials
      • 11.15.3 Product Portfolio
      • 11.15.4 Business Strategy
      • 11.15.5 Recent Developments
    • 11.16 Sysmex Corporation (Japan)
      • 11.16.1 Overview
      • 11.16.2 Financials
      • 11.16.3 Product Portfolio
      • 11.16.4 Business Strategy
      • 11.16.5 Recent Developments
    • 11.17 Ortho Clinical Diagnostics (US)
      • 11.17.1 Overview
      • 11.17.2 Financials
      • 11.17.3 Product Portfolio
      • 11.17.4 Business Strategy
      • 11.17.5 Recent Developments
    • 11.18 Luminex Corporation (US)
      • 11.18.1 Overview
      • 11.18.2 Financials
      • 11.18.3 Product Portfolio
      • 11.18.4 Business Strategy
      • 11.18.5 Recent Developments
    • 11.19 Meridian Bioscience (US)
      • 11.19.1 Overview
      • 11.19.2 Financials
      • 11.19.3 Product Portfolio
      • 11.19.4 Business Strategy
      • 11.19.5 Recent Developments
    • 11.20 Genetic Signatures (Australia)
      • 11.20.1 Overview
      • 11.20.2 Financials
      • 11.20.3 Product Portfolio
      • 11.20.4 Business Strategy
      • 11.20.5 Recent Developments
    • 11.21 OraSure Technologies (US)
      • 11.21.1 Overview
      • 11.21.2 Financials
      • 11.21.3 Product Portfolio
      • 11.21.4 Business Strategy
      • 11.21.5 Recent Developments
    • 11.22 Trinity Biotech Plc. (Ireland)
      • 11.22.1 Overview
      • 11.22.2 Financials
      • 11.22.3 Product Portfolio
      • 11.22.4 Business Strategy
      • 11.22.5 Recent Developments
    • 11.23 Chembio Diagnostic Systems Inc. (US)
      • 11.23.1 Overview
      • 11.23.2 Financials
      • 11.23.3 Product Portfolio
      • 11.23.4 Business Strategy
      • 11.23.5 Recent Developments
    • 11.24 Seegene Inc. (South Korea)
      • 11.24.1 Overview
      • 11.24.2 Financials
      • 11.24.3 Product Portfolio
      • 11.24.4 Business Strategy
      • 11.24.5 Recent Developments
    • 11.25 Co-Diagnostics Inc. (US)
      • 11.25.1 Overview
      • 11.25.2 Financials
      • 11.25.3 Product Portfolio
      • 11.25.4 Business Strategy
      • 11.25.5 Recent Developments
    • 11.26 ELITechGroup (France)
      • 11.26.1 Overview
      • 11.26.2 Financials
      • 11.26.3 Product Portfolio
      • 11.26.4 Business Strategy
      • 11.26.5 Recent Developments
    • 11.27 Epitope Diagnostics Inc. (US)
      • 11.27.1 Overview
      • 11.27.2 Financials
      • 11.27.3 Product Portfolio
      • 11.27.4 Business Strategy
      • 11.27.5 Recent Developments
    • 11.28 Trivitron Healthcare (India)
      • 11.28.1 Overview
      • 11.28.2 Financials
      • 11.28.3 Product Portfolio
      • 11.28.4 Business Strategy
      • 11.28.5 Recent Developments
    • 11.29 Meril Life Sciences Pvt. Ltd. (India)
      • 11.29.1 Overview
      • 11.29.2 Financials
      • 11.29.3 Product Portfolio
      • 11.29.4 Business Strategy
      • 11.29.5 Recent Developments
    • 11.30 InBios International Inc. (US)
      • 11.30.1 Overview
      • 11.30.2 Financials
      • 11.30.3 Product Portfolio
      • 11.30.4 Business Strategy
      • 11.30.5 Recent Developments
    • 11.31 ABACUS Diagnostica Oy (Finland).
      • 11.31.1 Overview
      • 11.31.2 Financials
      • 11.31.3 Product Portfolio
      • 11.31.4 Business Strategy
      • 11.31.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Infectious Disease Diagnostics Market attractiveness, By Product
  • 6. Global Infectious Disease Diagnostics Market attractiveness, By Type of Testing
  • 7. Global Infectious Disease Diagnostics Market attractiveness, By Technology
  • 8. Global Infectious Disease Diagnostics Market attractiveness, By Disease Type
  • 9. Global Infectious Disease Diagnostics Market attractiveness, By End-User
  • 10. Global Infectious Disease Diagnostics Market share by Product, 2022 and 2028 (USD Million)
  • 11. Global Infectious Disease Diagnostics Market by Reagents, Kits, and Consumables, 2022 - 2028 (USD Million)
  • 12. Global Infectious Disease Diagnostics Market by Instruments, 2022 - 2028 (USD Million)
  • 13. Global Infectious Disease Diagnostics Market by Software & Services, 2022 - 2028 (USD Million)
  • 14. Global Infectious Disease Diagnostics Market share by Type of Testing, 2022 and 2028 (USD Million)
  • 15. Global Infectious Disease Diagnostics Market by Laboratory Testing, 2022 - 2028 (USD Million)
  • 16. Global Infectious Disease Diagnostics Market by POC Testing, 2022 - 2028 (USD Million)
  • 17. Global Infectious Disease Diagnostics Market share by Technology, 2022 and 2028 (USD Million)
  • 18. Global Infectious Disease Diagnostics Market by Immunodiagnostics, 2022 - 2028 (USD Million)
  • 19. Global Infectious Disease Diagnostics Market by Clinical Microbiology, 2022 - 2028 (USD Million)
  • 20. Global Infectious Disease Diagnostics Market by PCR, 2022 - 2028 (USD Million)
  • 21. Global Infectious Disease Diagnostics Market by INAAT, 2022 - 2028 (USD Million)
  • 22. Global Infectious Disease Diagnostics Market by DNA Sequencing & NGS, 2022 - 2028 (USD Million)
  • 23. Global Infectious Disease Diagnostics Market by DNA Microarrays, 2022 - 2028 (USD Million)
  • 24. Global Infectious Disease Diagnostics Market by Other technologies, 2022 - 2028 (USD Million)
  • 25. Global Infectious Disease Diagnostics Market share by Disease Type, 2022 and 2028 (USD Million)
  • 26. Global Infectious Disease Diagnostics Market by COVID-19, 2022 - 2028 (USD Million)
  • 27. Global Infectious Disease Diagnostics Market by HIV, 2022 - 2028 (USD Million)
  • 28. Global Infectious Disease Diagnostics Market by HAIs, 2022 - 2028 (USD Million)
  • 29. Global Infectious Disease Diagnostics Market by Hepatitis, 2022 - 2028 (USD Million)
  • 30. Global Infectious Disease Diagnostics Market by CT/NG, 2022 - 2028 (USD Million)
  • 31. Global Infectious Disease Diagnostics Market by HPV, 2022 - 2028 (USD Million)
  • 32. Global Infectious Disease Diagnostics Market by TB, 2022 - 2028 (USD Million)
  • 33. Global Infectious Disease Diagnostics Market by Influenza, 2022 - 2028 (USD Million)
  • 34. Global Infectious Disease Diagnostics Market by Other Infectious Diseases, 2022 - 2028 (USD Million)
  • 35. Global Infectious Disease Diagnostics Market share by End-User, 2022 and 2028 (USD Million)
  • 36. Global Infectious Disease Diagnostics Market by Diagnostic Laboratories, 2022 - 2028 (USD Million)
  • 37. Global Infectious Disease Diagnostics Market by Hospitals & Clinics, 2022 - 2028 (USD Million)
  • 38. Global Infectious Disease Diagnostics Market by Academic Research Institutes, 2022 - 2028 (USD Million)
  • 39. Global Infectious Disease Diagnostics Market by Other End Users, 2022 - 2028 (USD Million)
  • 40. Global Infectious Disease Diagnostics Market share, by Region, 2022 and 2028
  • 41. North America Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
  • 42. Europe Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
  • 43. Asia Pacific Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
  • 44. Latin America Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
  • 45. The Middle-East and Africa Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)

Table Of Tables

  • 1. Global Infectious Disease Diagnostics Market: Snapshot
  • 2. Drivers of the Infectious Disease Diagnostics Market: impact analysis
  • 3. North America Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 4. North America Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 5. North America Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 6. North America Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 7. North America Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 8. U.S. Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 9. U.S. Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 10. U.S. Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 11. U.S. Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 12. U.S. Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 13. Canada Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 14. Canada Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 15. Canada Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 16. Canada Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 17. Canada Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 18. Europe Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 19. Europe Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 20. Europe Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 21. Europe Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 22. Europe Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 23. Germany Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 24. Germany Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 25. Germany Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 26. Germany Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 27. Germany Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 28. France Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 29. France Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 30. France Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 31. France Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 32. France Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 33. U.K. Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 34. U.K. Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 35. U.K. Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 36. U.K. Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 37. U.K. Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 38. Italy Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 39. Italy Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 40. Italy Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 41. Italy Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 42. Italy Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 43. Spain Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 44. Spain Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 45. Spain Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 46. Spain Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 47. Spain Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 48. Rest of Europe Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 49. Rest of Europe Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 50. Rest of Europe Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 51. Rest of Europe Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 52. Rest of Europe Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 53. Asia Pacific Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 54. Asia Pacific Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 55. Asia Pacific Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 56. Asia Pacific Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 57. Asia Pacific Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 58. China Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 59. China Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 60. China Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 61. China Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 62. China Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 63. Japan Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 64. Japan Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 65. Japan Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 66. Japan Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 67. Japan Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 68. India Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 69. India Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 70. India Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 71. India Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 72. India Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 73. South Korea Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 74. South Korea Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 75. South Korea Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 76. South Korea Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 77. South Korea Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 78. South-East Asia Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 79. South-East Asia Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 80. South-East Asia Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 81. South-East Asia Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 82. South-East Asia Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 83. Rest of Asia Pacific Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 84. Rest of Asia Pacific Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 85. Rest of Asia Pacific Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 86. Rest of Asia Pacific Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 87. Rest of Asia Pacific Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 88. Latin America Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 89. Latin America Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 90. Latin America Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 91. Latin America Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 92. Latin America Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 93. Brazil Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 94. Brazil Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 95. Brazil Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 96. Brazil Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 97. Brazil Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 98. Mexico Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 99. Mexico Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 100. Mexico Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 101. Mexico Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 102. Mexico Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 103. Rest of Latin America Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 104. Rest of Latin America Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 105. Rest of Latin America Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 106. Rest of Latin America Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 107. Rest of Latin America Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 108. The Middle-East and Africa Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 109. The Middle-East and Africa Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 110. The Middle-East and Africa Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 111. The Middle-East and Africa Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 112. The Middle-East and Africa Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 113. GCC Countries Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 114. GCC Countries Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 115. GCC Countries Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 116. GCC Countries Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 117. GCC Countries Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 118. South Africa Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 119. South Africa Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 120. South Africa Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 121. South Africa Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 122. South Africa Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 123. Rest of Middle-East Africa Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 124. Rest of Middle-East Africa Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 125. Rest of Middle-East Africa Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 126. Rest of Middle-East Africa Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 127. Rest of Middle-East Africa Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)

Methodology

FrequentlyAsked Questions

The prevalence of infectious diseases in developed and developing regions positively influenced the growth of the infectious disease diagnostics market and is expected to be a major factor in its growth during the forecast period. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for infectious disease diagnostic tests. These factors, alongside the growing trend for preventive medicine, are expected to drive the demand for the infectious disease diagnostics market.

According to the Market Research report, the global infectious disease diagnostics market was worth around USD 28152.7 million in 2021 and is estimated to grow to about USD 42013.25052 million by 2028, with a compound annual growth rate (CAGR) of approximately 6.9 percent over the forecast period.

The infectious disease diagnostics market is dominated by North America in 2020 and is expected to dominate the market during the forecast period due to the rise in occurrence of infectious diseases, presence of key players, development of the healthcare sector, presence of national clinical laboratories, advancement in technology for diagnostic instruments in the region, and an increase in awareness among the population regarding the availability of treatment devices. However, Asia-Pacific is expected to register the highest CAGR from 2021 to 2028.

Some of the main competitors dominating the global infectious disease diagnostics market include - Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Luminex Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems, Inc. (US), Seegene Inc. (South Korea), Co-Diagnostics, Inc. (US), ELITechGroup (France), Epitope Diagnostics, Inc. (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland).

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed